Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease

Mult Scler. 2004 Aug;10(4):348-54. doi: 10.1191/1352458504ms1045oa.

Abstract

The presence and the replicative state of human herpesvirus 6 (HHV-6) were evaluated in clinical samples from multiple sclerosis (MS) patients at the first time of MS diagnosis. HHV-6 variant B was present in peripheral blood mononuclear cells of 5/32 (15%) patients, but persisted with a latent infection. Viral sequences were present also in cerebrospinal fluid (CSF), both free in the liquid (7/32, 22%) and latent in the cellular fraction (3/32, 9%), as shown by analysis of viral transcription. In these cases, variant A was detected. HHV-6 DNA sequences present in the CSF were associated to mature viral particles. In fact, in vitro infectious assays of CSF showed the presence of replication-competent virions. These results show that about 20% of MS patients have active foci of HHV-6 variant A infection in the early stages of the disease and suggest that viral replication takes place within the central nervous system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Central Nervous System Diseases / blood
  • Central Nervous System Diseases / cerebrospinal fluid
  • Central Nervous System Diseases / complications*
  • Cerebrospinal Fluid / virology
  • DNA, Viral / cerebrospinal fluid
  • Enzyme-Linked Immunosorbent Assay
  • Herpesvirus 6, Human* / genetics
  • Herpesvirus 6, Human* / physiology
  • Humans
  • Multiple Sclerosis / blood
  • Multiple Sclerosis / cerebrospinal fluid
  • Multiple Sclerosis / complications*
  • Polymerase Chain Reaction
  • Prevalence
  • Reverse Transcriptase Polymerase Chain Reaction
  • Roseolovirus Infections / complications*
  • Roseolovirus Infections / epidemiology
  • Virion / physiology
  • Virus Latency
  • Virus Replication

Substances

  • DNA, Viral